Charles River Laboratories Completes the Acquisition of Cognate BioServices
WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed...
Find Out More
INTERVIEW: Thomas Moore, Sky News, reports on a new COVID-19 vaccine in development
Thomas Moore, Science and Medical Correspondent Sky News, is joined by Prof. Lindy Durrant, immunologist and joint CEO/CSO of Scancell, and Alex...
Find Out More
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Providing large scale manufacturing capacity for AZD1222
Find Out More
Get In Touch
Speak to a member of our expert Advanced Therapies team and arrange to take a tour of our GMP facilities in the UK and Sweden.
